These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 12490409

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The role of NO in macrophage dysfunction at early stage after burn injury.
    Luo G, Peng D, Zheng J, Chen X, Wu J, Elster E, Tadaki D.
    Burns; 2005 Mar; 31(2):138-44. PubMed ID: 15683683
    [Abstract] [Full Text] [Related]

  • 23. 12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.
    Gao X, Ikuta K, Tajima M, Sairenji T.
    Virology; 2001 Jul 20; 286(1):91-9. PubMed ID: 11448162
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S.
    J Virol; 2004 Apr 20; 78(8):4197-206. PubMed ID: 15047835
    [Abstract] [Full Text] [Related]

  • 26. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ, Allday MJ.
    J Gen Virol; 2000 Jun 20; 81(Pt 6):1567-78. PubMed ID: 10811940
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A, Arena G, Stecca C, Raciti M, Mattia E.
    Mol Cancer Res; 2011 Oct 20; 9(10):1346-55. PubMed ID: 21856773
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
    Wu CC, Fang CY, Hsu HY, Chen YJ, Chou SP, Huang SY, Cheng YJ, Lin SF, Chang Y, Tsai CH, Chen JY.
    Antiviral Res; 2016 Aug 20; 132():99-110. PubMed ID: 27185626
    [Abstract] [Full Text] [Related]

  • 35. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT, Wang YT, Chen YJ, Lin SF, Tsai CH, Chen MR.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228591
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 01; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
    Nandakumar A, Uwatoko F, Yamamoto M, Tomita K, Majima HJ, Akiba S, Koriyama C.
    Tumour Biol; 2017 Jul 01; 39(7):1010428317717718. PubMed ID: 28675108
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.